Michael John Sumner - 26 Feb 2026 Form 4 Insider Report for INOVIO PHARMACEUTICALS, INC. (INO)

Role: Chief Medical Officer
Signature: /s/ Michael John Sumner
Issuer symbol: INO
Transactions as of: 26 Feb 2026
Net transactions value: -$6,986
Form type: 4
Filing time: 27 Feb 2026, 16:47:13 UTC
Previous filing: 01 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Sumner Michael John	Chief Medical Officer	660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING	/s/ Michael John Sumner	27 Feb 2026	0001936799

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	INO	Common Stock	Options Exercise		+5,010	+28%		22,860	26 Feb 2026	Direct	F1
transaction	INO	Common Stock	Options Exercise		+11,550	+51%		34,410	26 Feb 2026	Direct	F2
transaction	INO	Common Stock	Tax liability	$6,986	-3,903	-11%	$1.79	30,507	26 Feb 2026	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-5,010	-50%	$0.000000	5,009	26 Feb 2026	Common Stock	5,010		Direct	F1
transaction	INO	Restricted Stock Unit	Options Exercise	$0	-11,550	-33%	$0.000000	23,100	26 Feb 2026	Common Stock	11,550		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F2	Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 was as follows: 11,550 shares vested on February 26, 2026; 11,550 shares will vest on February 26, 2027; 11,550 shares will vest on February 26, 2028. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F3	The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (2) herein.